Journey Medical Acquires Topical Minocycline Products | MedEsthetics
Zilxi (minocycline topical foam)
Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea
VYNE Therapeutics' ZILXI Topical Minocycline Foam Now Available in Pharmacies Nationwide | MedEsthetics
FDA Approves Zilxi (minocycline) Topical Foam for the Treatment of Rosacea-CliniExpert
Zilxi™ | Patient Resources
Zilxi™ | Topical Minocycline
These highlights do not include all the information needed to use ZILXI safely and effectively. See full prescribing information for ZILXI. ZILXI® (minocycline) topical foamInitial U.S. Approval: 1971